4.0 Article

Validation of the Microlife WatchBP O3 device for clinic, home, and ambulatory blood pressure measurement, according to the International Protocol

期刊

BLOOD PRESSURE MONITORING
卷 15, 期 1, 页码 59-62

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MBP.0b013e32833531ca

关键词

ambulatory blood pressure; device; hypertension; self measurement; validation

资金

  1. Microlife WatchBP AG, Espenstrasee 139, CH 9443, Widnau, Switzerland

向作者/读者索取更多资源

To determine the accuracy of the Microlife WatchBP O3 blood pressure measuring device tested according to the requirements of the International Protocol of the European Society of Hypertension. The WatchBP O3 is designed to provide clinic, ambulatory, and self blood pressure (BP) measurements. Device evaluation was performed in 33 participants with a mean +/- standard deviation age of 56.1 +/- 20.7 years (range 30-95 years). Their systolic BP (SBP) was 144.7 +/- 24.1 mmHg (range 90-180 mmHg), diastolic BP (DBP) was 86.8 +/- 18.3 mmHg (range 50-120 mmHg), and arm circumference was 28.1 +/- 2.9 cm (range 22.0-34.0 cm). Blood pressure measurements were performed in the sitting position. The WatchBP 03 passed all three phases of the European Society of Hypertension protocol for SBP and DBP. Mean blood pressure differences for the WatchBP 03 (device observer) were -1.7 +/- 6.9 mmHg for SBP and -1.1 +/- 4.3 mmHg for DBP. In conclusion, these results indicate that the Microlife WatchBP 03 monitor can be recommended for clinical use in the adult population. Blood Press Monit 15:59-62 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据